Last reviewed · How we verify
DC371739 Tablets
At a glance
| Generic name | DC371739 Tablets |
|---|---|
| Sponsor | Guangzhou JOYO Pharma Co., Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Ascending-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics of DC371739 Single-Dose Treatment in Healthy Subjects (PHASE1)
- Multiple Ascending Dose Study to Evaluate the Safety, Tolerability of DC371739 Treatment in Hypercholesterolemic (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DC371739 Tablets CI brief — competitive landscape report
- DC371739 Tablets updates RSS · CI watch RSS
- Guangzhou JOYO Pharma Co., Ltd portfolio CI